Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II StudyBrittany Knick Ragon, Nitin Jain, Olatoyosi Odenike et al.|Clinical Lymphoma Myeloma & Leukemia|2019Cited by 67
Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE NetworkCarlos J. Gallego, Gail P. Jarvik, C. Shaw et al.|The American Journal of Human Genetics|2015Cited by 65